Malaria

Medicine (United Kingdom)

Volumn 42, Issue 2, 2014, Pages 100-106

  Walker, Naomi F ^a,b   Nadjm, Behzad ^c,d   Whitty, Christopher J M ^e,f  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^e HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Anopheles; antimalarials; falciparum; knowlesi; malaria; malariae; ovale; Plasmodium; vivax

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; CHLOROQUINE; CLINDAMYCIN; DOXYCYCLINE; INFUSION FLUID; PRIMAQUINE; QUININE;

ANOPHELES; ARTICLE; BLOOD TRANSFUSION; BLURRED VISION; CLINICAL FEATURE; DIZZINESS; EARLY DIAGNOSIS; ENDEMIC DISEASE; GASTRITIS; GLYCOGEN STORAGE DISEASE TYPE 1; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; HYPOGLYCEMIA; MALARIA FALCIPARUM; MORBIDITY; MORTALITY; NAUSEA; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHOTOSENSITIVITY DISORDER; PLASMODIUM KNOWLESI MALARIA; PLASMODIUM MALARIAE INFECTION; PLASMODIUM OVALE MALARIA; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; TASTE DISORDER; TINNITUS; TRAVEL; UNITED KINGDOM;

EID: 84893381547     PISSN: 13573039     EISSN: 13654357     Source Type: Journal    
DOI: 10.1016/j.mpmed.2013.11.011     Document Type: Review

References (23)

1. World malaria report 2012 2012 World Health Organization Geneva
2. A.M. Dondorp, R.M. Fairhurst, and L. Slutsker et al. The threat of artemisinin-resistant malaria N Engl J Med 365 2011 1073 1075
3. P. Gautret, P. Schlagenhauf, and J. Gaudart et al. Multicenter EuroTravNet/GeoSentinel study of travel-related infectious diseases in Europe Emerg Infect Dis 15 2009 1783 1790
4. A.M. Checkley, A. Smith, and V. Smith et al. Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study Br Med J 344 2012 e2116
5. M.E. Marks, M. Armstrong, and M.M. Suvari et al. Severe imported falciparum malaria among adults requiring intensive care: a retrospective study at the hospital for tropical diseases, London BMC Infect Dis 13 2013 118
6. T. Jelinek Imported falciparum malaria in Europe: 2007 data from TropNetEurop Euro Surveill 13 2008 pii; 18895
7. L.H. Miller, H.C. Ackerman, X.Z. Su, and T.E. Wellems Malaria biology and disease pathogenesis: insights for new treatments Nat Med 19 2013 156 167
8. E.M. Riley, and V.A. Stewart Immune mechanisms in malaria: new insights in vaccine development Nat Med 19 2013 168 178
9. C. Nic Fhogartaigh, H. Hughes, and M. Armstrong et al. Falciparum malaria as a cause of fever in adult travellers returning to the United Kingdom: observational study of risk by geographical area QJM 101 2008 649 656
10. WHO Guidelines for the treatment of Malaria 2nd edn 2010 World Health Organization Geneva
11. R.D. Newman, M.E. Parise, A.M. Barber, and R.W. Steketee Malaria-related deaths among U.S. travelers, 1963-2001 Ann Intern Med 141 2004 547 555
12. C.K. Murray, R.A. Gasser Jr., A.J. Magill, and R.S. Miller Update on rapid diagnostic testing for malaria Clin Microbiol Rev 21 2008 97 110
13. D.G. Lalloo, D. Shingadia, and G. Pasvol et al. UK malaria treatment guidelines J Infect 54 2007 111 121
14. A. Dondorp, F. Nosten, K. Stepniewska, N. Day, and N. White Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial Lancet 366 2005 717 725
15. A.M. Dondorp, C.I. Fanello, and I.C. Hendriksen et al. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial Lancet 376 2010 1647 1657
16. D. Sinclair, S. Donegan, R. Isba, and D.G. Lalloo Artesunate versus quinine for treating severe malaria Cochrane Database Syst Rev 2012 Issue 6. Art. No.: CD005967
17. M. Eder, H. Farne, T. Cargill, A. Abbara, and R.N. Davidson Intravenous artesunate versus intravenous quinine in the treatment of severe falciparum malaria: a retrospective evaluation from a UK centre Pathogens Glob Health 106 2012 181 187
18. British National Formulary 65 2013 BMJ Publishing Group Ltd and Royal Pharmaceutical Society London
19. K. Maitland, A. Babiker, S. Kiguli, and E. Molyneux The FEAST trial of fluid bolus in African children with severe infection Lancet 379 2012 613 author reply 13-14
20. B. Nadjm, G. Mtove, and B. Amos et al. Severe febrile illness in adult hospital admissions in Tanzania: a prospective study in an area of high malaria transmission Trans R Soc Trop Med Hyg 106 2012 688 695
21. M.S. Riddle, J.L. Jackson, J.W. Sanders, and D.L. Blazes Exchange transfusion as an adjunct therapy in severe Plasmodium falciparum malaria: a meta-analysis Clin Infect Dis 34 2002 1192 1198
22. E.N. Takem, and U. D'Alessandro Malaria in pregnancy Mediterr J Hematol Infect Dis 5 2013 e2013010
23. A.D. Smith, D.J. Bradley, and V. Smith et al. Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006 Br Med J 337 2008 a120